THCA Shows Promise for Huntington’s Disease, Study Finds

The compound THCA derived from cannabis could be used one day to treat Huntington’s Disease and other neurodegenerative and neuroinflammatory diseases, according to a study published recently in the British Journal of Pharmacology.

Researchers found that THCA, an acidic precursor of THC, reduced inflammation and served as a neuroprotectant when they analyzed cannabis compounds in animals. In the study, the compound improved motor function and prevented brain degeneration.

“I think we have something here and it’s pretty exciting,” Gaetano Morello, a co-author of the study, said in an interview with Leafly. Morello is a cannabis researcher and naturopathic physician in the Complex Chronic Disease Program at B.C. Women’s Hospital and Health Centre in Vancouver.

What Is THCA?

THCA is a natural cannabinoid found in raw and live cannabis. As the plant dries, THCA is slowly converted to THC. Heat rapidly quickens that conversion in a process

... read more at: https://www.leafly.com/news/science-tech/thca-shows-promise-for-huntingtons-disease-study-finds

by

Leave a Reply

Your email address will not be published. Required fields are marked *